Khan M, Zugaza J, Torres Aleman I
J Biol Chem. 2024; 301(1):108047.
PMID: 39638246
PMC: 11748690.
DOI: 10.1016/j.jbc.2024.108047.
Barik P, Kuo W, Kuo C, Hsieh D, Day C, Daddam J
Aging (Albany NY). 2023; 15(23):14019-14038.
PMID: 38085649
PMC: 10756089.
DOI: 10.18632/aging.205287.
Peloso Maia M, Albuquerque R, do Carmo Silva S, Lima C, Diniz P, Vidigal P
Oncology. 2023; 102(6):494-502.
PMID: 37989120
PMC: 11152013.
DOI: 10.1159/000535332.
Soni U, Jenny L, Hegde R
J Exp Clin Cancer Res. 2023; 42(1):273.
PMID: 37858153
PMC: 10588251.
DOI: 10.1186/s13046-023-02850-7.
Werner H
Int J Mol Sci. 2023; 24(19).
PMID: 37834331
PMC: 10573540.
DOI: 10.3390/ijms241914882.
IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia.
Zheng K, Sha N, Hou G, Leng Z, Zhao Q, Zhang L
Nat Commun. 2023; 14(1):6117.
PMID: 37777542
PMC: 10542766.
DOI: 10.1038/s41467-023-41658-z.
Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival.
Chen Y, Leibovitch M, Zeinieh M, Jabado N, Brodt P
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259440
PMC: 9964639.
DOI: 10.3390/ph16020297.
Drugging IGF-1R in cancer: New insights and emerging opportunities.
Wang P, Mak V, Cheung L
Genes Dis. 2023; 10(1):199-211.
PMID: 37013053
PMC: 10066341.
DOI: 10.1016/j.gendis.2022.03.002.
Hallmarks of cancer: The insulin-like growth factors perspective.
Werner H, LeRoith D
Front Oncol. 2022; 12:1055589.
PMID: 36479090
PMC: 9720135.
DOI: 10.3389/fonc.2022.1055589.
Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition.
Soni U, Wang Y, Pandey R, Roberts R, Pressey J, Hegde R
Clin Cancer Res. 2022; 29(2):458-471.
PMID: 36394520
PMC: 9843438.
DOI: 10.1158/1078-0432.CCR-22-2587.
Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.
Yoshihiro T, Ariyama H, Yamaguchi K, Imajima T, Yamaga S, Tsuchihashi K
Cancer Sci. 2022; 113(12):4207-4218.
PMID: 36053154
PMC: 9746063.
DOI: 10.1111/cas.15558.
Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer's Disease.
Leung H, Foo G, VanDongen A
Biomedicines. 2022; 10(8).
PMID: 36009494
PMC: 9405677.
DOI: 10.3390/biomedicines10081946.
Type 1 Insulin-Like Growth Factor Receptor Nuclear Localization in High-Grade Glioma Cells Enhances Motility, Metabolism, and Tumorigenesis.
Martin A, Fernandez M, Cattaneo E, Schuster C, Venara M, Clement F
Front Endocrinol (Lausanne). 2022; 13:849279.
PMID: 35574033
PMC: 9094447.
DOI: 10.3389/fendo.2022.849279.
Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy.
Giatagana E, Berdiaki A, Gaardlos M, Samsonov S, N Tzanakakis G, Nikitovic D
Cancers (Basel). 2022; 14(5).
PMID: 35267503
PMC: 8909324.
DOI: 10.3390/cancers14051196.
IGFBP-3 functions as a molecular switch that mediates mitochondrial and metabolic homeostasis.
Stuard W, Titone R, Robertson D
FASEB J. 2021; 36(1):e22062.
PMID: 34918377
PMC: 9060658.
DOI: 10.1096/fj.202100710RR.
The IGF-1 Signaling Pathway in Viral Infections.
Jozefiak A, Larska M, Pomorska-Mol M, Ruszkowski J
Viruses. 2021; 13(8).
PMID: 34452353
PMC: 8402757.
DOI: 10.3390/v13081488.
Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer.
Yang C, Zhang Y, Segar N, Huang C, Zeng P, Tan X
Oncol Rep. 2021; 46(2).
PMID: 34165167
PMC: 8250583.
DOI: 10.3892/or.2021.8119.
Asporin represses gastric cancer apoptosis via activating LEF1-mediated gene transcription independent of β-catenin.
Zhang Z, Min L, Li H, Chen L, Zhao Y, Liu S
Oncogene. 2021; 40(27):4552-4566.
PMID: 34127813
DOI: 10.1038/s41388-021-01858-7.
IGFBP-3 Mediates Metabolic Homeostasis During Hyperosmolar Stress in the Corneal Epithelium.
Bogdan E, Stuard W, Titone R, Robertson D
Invest Ophthalmol Vis Sci. 2021; 62(7):11.
PMID: 34100890
PMC: 8196413.
DOI: 10.1167/iovs.62.7.11.
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis.
N Tzanakakis G, Giatagana E, Berdiaki A, Spyridaki I, Hida K, Neagu M
Cancers (Basel). 2021; 13(10).
PMID: 34069554
PMC: 8160938.
DOI: 10.3390/cancers13102478.